Acute myeloid leukemia (AML) is a clonal hematologic malignant disease of developing myeloid cells that have acquired aberrant survival, uncontrolled proliferation and a block in normal hematopoietic ...
Phase II trial of cladribine and low-dose AraC alternating with decitabine in older patients with AML. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results